CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)

[China Jo-Jo Drugstores, Inc. Receives Delisting Notice from NASDAQ HANGZHOU, China--(PR NEWS WIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today announced that on May 9, 2013, it was notified by The NASDAQ Stock Market LLC (“NASDAQ”), notifying it of its failure to maintain a minimum closing bid]

CJJD [CHINA JO-JO DRUGSTORES] 8-K: China Jo-Jo Drugstores, Inc. Receives Delisting Notice from

[China Jo-Jo Drugstores, Inc. Receives Delisting Notice from NASDAQ HANGZHOU, China--(PR NEWS WIRE)--China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) (the “Company”), a retail and wholesale distributor of pharmaceutical and other healthcare products in China, today announced that on May 9, 2013, it was notified by The NASDAQ Stock Market LLC (“NASDAQ”), notifying it of its failure to maintain a minimum closing bid]

EGT [Entertainment Gaming Asia] 8-K: (Original Filing)

[CONTACTS: Entertainment Gaming Asia Inc. Traci Mangini tracimangini@EGT-Group.com 312/867-0848 RESULTS ENTERTAINMENT GAMING ASIA REPORTS FIRST QUARTER 2013 AND PROVIDES MARKET UPDATE Hong Kong – May 10, 2013 – Entertainment Gaming Asia Inc. (NASDAQ: EGT) (“Entertainment Gaming Asia” or “the Company”), a leading gaming company focused on emerging gaming markets in Pan-Asia, today reported operating results for the first quarter ended] [ENTERTAINMENT GAMING ASIA INC. Nevada 001-32161 91-1696010 (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification Number) Unit C1, Ground Floor, Koon Wah Building No. 2 Yuen Shun Circuit Yuen Chau Kok, Shatin New Territories, Hong Kong SAR + 852-3147-6600 Not applicable (Former name or former address, if changed since last report) o o o o Item 2.02 Results of]

EGT [Entertainment Gaming Asia] 8-K: CONTACTS: Entertainment Gaming Asia Inc. Traci Mangini tracimangini@EGT-Group.com

[CONTACTS: Entertainment Gaming Asia Inc. Traci Mangini tracimangini@EGT-Group.com 312/867-0848 RESULTS ENTERTAINMENT GAMING ASIA REPORTS FIRST QUARTER 2013 AND PROVIDES MARKET UPDATE Hong Kong – May 10, 2013 – Entertainment Gaming Asia Inc. (NASDAQ: EGT) (“Entertainment Gaming Asia” or “the Company”), a leading gaming company focused on emerging gaming markets in Pan-Asia, today reported operating results for the first quarter ended] [ENTERTAINMENT GAMING ASIA INC. Nevada 001-32161 91-1696010 (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification Number) Unit C1, Ground Floor, Koon Wah Building No. 2 Yuen Shun Circuit Yuen Chau Kok, Shatin New Territories, Hong Kong SAR + 852-3147-6600 Not applicable (Former name or former address, if changed since last report) o o o o Item 2.02 Results of]

By | 2016-03-13T23:25:42+00:00 May 10th, 2013|Categories: Chinese Stocks, EGT, Webplus ver|Tags: , , , , , |0 Comments

TPI [TIANYIN PHARMACEUTICAL] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT FOR ISSUERS SUBJECT TO THE CURRENT REPORT May 8, 2013 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co., Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28-8615-4737 o o o]

By | 2016-03-27T18:29:59+00:00 May 9th, 2013|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments

CBPO [China Biologic Products] 8-K: (Original Filing)

[FOR RELEASE May 8, 2013 China Biologic Reports Financial Results for the First Quarter of 2013 1Q13 Total Sales Increases 14.4% to $54.0 Million 1Q13 Operating Margin Increases to 48.1% from 1Q13 Non-GAAP Net Income 29.0% to $16.4 Million Increases BEIJING, China – May 8, 2013 – First Quarter 2013 Financial Highlights · Total sales · Gross profit · Income] []

CBPO [China Biologic Products] 8-K: FOR RELEASE May 8, 2013 China Biologic Reports

[FOR RELEASE May 8, 2013 China Biologic Reports Financial Results for the First Quarter of 2013 1Q13 Total Sales Increases 14.4% to $54.0 Million 1Q13 Operating Margin Increases to 48.1% from 1Q13 Non-GAAP Net Income 29.0% to $16.4 Million Increases BEIJING, China – May 8, 2013 – First Quarter 2013 Financial Highlights · Total sales · Gross profit · Income] []

BSPM [Biostar Pharmaceuticals,] 8-K: (Original Filing)

[______________ FORM 8-K ______________ CURRENT REPORT Date of Report (Date of earliest event reported): May 1, 2013 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨]

By | 2016-03-03T11:08:55+00:00 May 6th, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 8-K: ______________ FORM 8-K ______________ CURRENT REPORT Date of

[______________ FORM 8-K ______________ CURRENT REPORT Date of Report (Date of earliest event reported): May 1, 2013 BIOSTAR PHARMACEUTICALS, INC. Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province People’s Republic of China 712046 86-029-33686638 N/A (Former name or former address, if changed since last report) ¨]

By | 2016-03-03T11:10:18+00:00 May 6th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar